Bernard Munos

Bernard Munos is a pharmaceutical executive and director who has spent their career in the industry researching and developing new treatments. Bernard is currently the Director at Glenmark Pharmaceuticals. Prior to this, they were a Scientist at Science.com, and before that, they held positions at Stellate Therapeutics (formerly Amabiotics), AsedaSciences, Open Source Pharma Foundation, and University of California, San Francisco. In addition to their work in the pharmaceutical industry, Bernard has also been involved with the Milken Institute's FasterCures organization and the InnoThink Center for Research in Biomedical Innovation.

Bernard Munos has an MBA from Stanford University Graduate School of Business, an MS from University of California, Davis, and an M.Sc. Eng. from AgroParisTech - Institute of Technology for Life, Food and Environmental Sciences. Bernard also has executive education in corporate valuation from Harvard Business School.